Resources

Immunization is a success story for global health and development, saving millions of lives every year at relatively low costs. However, each year, about 20 million infants do not receive the full course of the basic vaccines, with over 50% of them not receiving any vaccines. At the Addis Declaration on Immunization in 2016, African leaders committed to support immunization with the goal of ensuring that every African benefits from immunization.Reflecting on these commitments, PATH set out to assess the progress in the implementation of the Addis Declaration in ten selected countries. A retrospective study on the status of immunization financing, including the factors affecting adequate financing for immunization, was conducted by reviewing secondary data from various sources including global and country-based immunization and health databases and published peer reviewed and gray literature.The following resources include a technical brief detailing the key findings, the full report, and country-specific profiles.

Malaria is a major public health problem in the Democratic Republic of the Congo (DRC). It is the leading cause of morbidity and mortality in DRC, with 27.3 million cases of malaria and 24,880 malaria deaths reported in 2022.An effective surveillance, monitoring and evaluation (M&E) system that produces high quality data is essential for the monitoring of malaria trends, evaluation of the impact of malaria control interventions, and evidence-based decision-making. Problems with the quality of malaria data persist in the DRC, limiting the national malaria control program’s (NMCP) informed decision-making and ability to launch a timely response to identified priorities.To address this need, the DRC NMCP – with support from PATH MACEPA – has developed a decentralized routine data quality audit (RDQA) process that was piloted in four health zones in Haut-Katanga. Pilot methodology, preliminary results, and key recommendations are summarized in this technical brief.

Malaria is a major public health problem in the Democratic Republic of the Congo (DRC). It is the leading cause of morbidity and mortality in DRC, with 27.3 million cases of malaria and 24,880 malaria deaths reported in 2022.An effective surveillance, monitoring and evaluation (M&E) system that produces high quality data is essential for the monitoring of malaria trends, evaluation of the impact of malaria control interventions, and evidence-based decision-making. Problems with the quality of malaria data persist in the DRC, limiting the national malaria control program’s (NMCP) informed decision-making and ability to launch a timely response to identified priorities.To address this need, the DRC NMCP – with support from PATH MACEPA – has developed a decentralized routine data quality audit (RDQA) process that was piloted in four health zones in Haut-Katanga. An overview of the pilot, preliminary results, and next steps are summarized in this brief.

Microarray patch technology has the potential to foster untold gains in access, efficacy, and adherence for vaccines and essential medicines. PATH is working to accelerate the development of this innovative delivery technology platform to address critical public health needs. PATH is collaborating with microarray patch (MAP) developers, vaccine and drug manufacturers, and other global stakeholders to evaluate and advance a range of MAPs at varying stages of product development, with the aim of improving access and equity in the delivery of vaccines and essential medicines in resource constrained settings.

PATH is implementing a district saturation project in Satara, Maharashtra to enhance quality primary health care (PHC) for all. Through a multi-faceted approach including human-centered design, integration and comprehensive PHC benefit package, gender and climate lens, fit-for-purpose digital technology, human resource for health (HRH) and community engagement, the project aims to establish a replicable model for providing comprehensive PHC. It focuses on strengthening the continuum of care, adding locally tailored health services, leveraging digital solutions, ensuring quality accreditation for health facilities, improving retention of HRH and fostering community involvement. Innovative initiatives, such as care for non-communicable disease and snake-bite envenoming packages, underscore its commitment to addressing local health needs effectively.